Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Gene Therapy-based Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Akcea Therapeutics
AnGes
bluebird bio
Spark Therapeutics
Sarepta Therapeutics
Biogen
Sunway Biotech
Novartis
Human Stem Cells Institute
Gilead Sciences
SIBIONO
Orchard Therapeutics
Alnylam Pharmaceuticals
Amgen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
Application:
Neurological Diseases
Cancer
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Gene Therapy-based Drug Industry Overview
-
1.1.1 Gene Therapy-based Drug Market Scope and Market Segments
-
1.1.2 Gene Therapy-based Drug Industry Characteristics
-
1.1.3 Global and China Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Gene Therapy-based Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Gene Therapy-based Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Viral Gene Delivery System
-
1.2.2 Non-viral Gene Delivery System
-
1.3 Global Gene Therapy-based Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Neurological Diseases
-
1.3.2 Cancer
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Gene Therapy-based Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Gene Therapy-based Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Gene Therapy-based Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Gene Therapy-based Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Gene Therapy-based Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Gene Therapy-based Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Gene Therapy-based Drug Industry PEST Analysis
-
2.3 Gene Therapy-based Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Gene Therapy-based Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Gene Therapy-based Drug Industry
Chapter 3 Global and China Gene Therapy-based Drug Market, by Manufacturer
-
3.1 Global and China Gene Therapy-based Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Gene Therapy-based Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Gene Therapy-based Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Gene Therapy-based Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Gene Therapy-based Drug Market Top 3 Players
Chapter 4 Global and China Gene Therapy-based Drug Market, by Type (2017-2028)
-
4.1 Gene Therapy-based Drug Market Trend, by Type
-
4.2 Global Gene Therapy-based Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Gene Therapy-based Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Gene Therapy-based Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Gene Therapy-based Drug Price Trend, by Type (2017-2028)
-
4.3 China Gene Therapy-based Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Gene Therapy-based Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Gene Therapy-based Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Gene Therapy-based Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Gene Therapy-based Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Gene Therapy-based Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Gene Therapy-based Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Gene Therapy-based Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Gene Therapy-based Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Gene Therapy-based Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Gene Therapy-based Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Gene Therapy-based Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Gene Therapy-based Drug Market Analysis
-
7.1 North America Gene Therapy-based Drug Market, by Type
-
7.2 North America Gene Therapy-based Drug Market, by Application
-
7.3 North America Gene Therapy-based Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Gene Therapy-based Drug Market Analysis
-
8.1 Europe Gene Therapy-based Drug Market, by Type
-
8.2 Europe Gene Therapy-based Drug Market, by Application
-
8.3 Europe Gene Therapy-based Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Gene Therapy-based Drug Market Analysis
-
9.1 APAC Gene Therapy-based Drug Market, by Type
-
9.2 APAC Gene Therapy-based Drug Market, by Application
-
9.3 APAC Gene Therapy-based Drug Market Analysis and Forecast, by Country
-
9.3.1 China Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Gene Therapy-based Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Gene Therapy-based Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Gene Therapy-based Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Gene Therapy-based Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Gene Therapy-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Gene Therapy-based Drug Company Profiles
-
11.1 Akcea Therapeutics
-
11.1.1 Akcea Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Akcea Therapeutics Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.1.3 Akcea Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 AnGes
-
11.2.1 AnGes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 AnGes Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.2.3 AnGes Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 bluebird bio
-
11.3.1 bluebird bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 bluebird bio Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.3.3 bluebird bio Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Spark Therapeutics
-
11.4.1 Spark Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Spark Therapeutics Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.4.3 Spark Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Sarepta Therapeutics
-
11.5.1 Sarepta Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Sarepta Therapeutics Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.5.3 Sarepta Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Biogen
-
11.6.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Biogen Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.6.3 Biogen Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Sunway Biotech
-
11.7.1 Sunway Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Sunway Biotech Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.7.3 Sunway Biotech Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Novartis
-
11.8.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Novartis Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.8.3 Novartis Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Human Stem Cells Institute
-
11.9.1 Human Stem Cells Institute Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Human Stem Cells Institute Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.9.3 Human Stem Cells Institute Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Gilead Sciences
-
11.10.1 Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Gilead Sciences Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.10.3 Gilead Sciences Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 SIBIONO
-
11.11.1 SIBIONO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 SIBIONO Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.11.3 SIBIONO Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Orchard Therapeutics
-
11.12.1 Orchard Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Orchard Therapeutics Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.12.3 Orchard Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Alnylam Pharmaceuticals
-
11.13.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Alnylam Pharmaceuticals Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.13.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Amgen
-
11.14.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Amgen Gene Therapy-based Drug Product Profiles, Application and Specification
-
11.14.3 Amgen Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Gene Therapy-based Drug Industry Investment Prospect and Risk Assessment
-
12.1 Gene Therapy-based Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Gene Therapy-based Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Gene Therapy-based Drug Production Value and Growth Rate (2017-2028)
-
Figure China Gene Therapy-based Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Gene Therapy-based Drug Market Size and Growth Rate of Viral Gene Delivery System (2017-2028)
-
Figure Global Gene Therapy-based Drug Market Size and Growth Rate of Non-viral Gene Delivery System (2017-2028)
-
Figure Global Gene Therapy-based Drug Market Size and Growth Rate of Neurological Diseases (2017-2028)
-
Figure Global Gene Therapy-based Drug Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global Gene Therapy-based Drug Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Gene Therapy-based Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Gene Therapy-based Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Gene Therapy-based Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapy-based Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapy-based Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Gene Therapy-based Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Gene Therapy-based Drug Market Share, by Manufacturer in 2022
-
Table Global Gene Therapy-based Drug Sales Volume, by Type (2017-2028)
-
Table Global Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Gene Therapy-based Drug Sales Value, by Type (2017-2028)
-
Table Global Gene Therapy-based Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Gene Therapy-based Drug Price Trend, by Type (2017-2028)
-
Table China Gene Therapy-based Drug Sales Volume, by Type (2017-2028)
-
Table China Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Table China Gene Therapy-based Drug Sales Value, by Type (2017-2028)
-
Table China Gene Therapy-based Drug Sales Value Share, by Type (2017-2028)
-
Figure China Gene Therapy-based Drug Price Trend, by Type (2017-2028)
-
Table Global Gene Therapy-based Drug Sales Volume, by Application (2017-2028)
-
Table Global Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Gene Therapy-based Drug Sales Value, by Application (2017-2028)
-
Table Global Gene Therapy-based Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Gene Therapy-based Drug Sales Value Share, by Application (2017-2028)
-
Table China Gene Therapy-based Drug Sales Volume, by Application (2017-2028)
-
Table China Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Table China Gene Therapy-based Drug Sales Value, by Application (2017-2028)
-
Table China Gene Therapy-based Drug Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapy-based Drug Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Gene Therapy-based Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Gene Therapy-based Drug Sales Volume, by Type (2017-2028)
-
Table North America Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Gene Therapy-based Drug Sales Volume, by Application (2017-2028)
-
Table North America Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Gene Therapy-based Drug Sales Volume, by Type (2017-2028)
-
Table Europe Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Gene Therapy-based Drug Sales Volume, by Application (2017-2028)
-
Table Europe Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Gene Therapy-based Drug Sales Volume, by Type (2017-2028)
-
Table APAC Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Gene Therapy-based Drug Sales Volume, by Application (2017-2028)
-
Table APAC Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy-based Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy-based Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy-based Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapy-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapy-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapy-based Drug Sales Value and Growth Rate (2017-2028)
-
Table Akcea Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Akcea Therapeutics Product Profiles, Application and Specification
-
Table Akcea Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AnGes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AnGes Product Profiles, Application and Specification
-
Table AnGes Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table bluebird bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table bluebird bio Product Profiles, Application and Specification
-
Table bluebird bio Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Spark Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Spark Therapeutics Product Profiles, Application and Specification
-
Table Spark Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sarepta Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sarepta Therapeutics Product Profiles, Application and Specification
-
Table Sarepta Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Product Profiles, Application and Specification
-
Table Biogen Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sunway Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sunway Biotech Product Profiles, Application and Specification
-
Table Sunway Biotech Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Human Stem Cells Institute Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Human Stem Cells Institute Product Profiles, Application and Specification
-
Table Human Stem Cells Institute Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gilead Sciences Product Profiles, Application and Specification
-
Table Gilead Sciences Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SIBIONO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SIBIONO Product Profiles, Application and Specification
-
Table SIBIONO Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Orchard Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Orchard Therapeutics Product Profiles, Application and Specification
-
Table Orchard Therapeutics Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alnylam Pharmaceuticals Product Profiles, Application and Specification
-
Table Alnylam Pharmaceuticals Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Gene Therapy-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
